Philips' RADIQAL Study: Revolutionising Coronary Procedures with Ultra-Low X-ray Dose Technology

ADVERTISEMENT
2025-05-20
Philips' RADIQAL Study: Revolutionising Coronary Procedures with Ultra-Low X-ray Dose Technology
The Manila Times

Philips Healthcare is pioneering a new era in cardiovascular care with the launch of the RADIQAL study, a landmark initiative designed to gather real-world evidence supporting its innovative ultra-low X-ray dose technology. This technology promises ...Read more

Recommendations
Recommendations